Chemists are, for the first time, using a new tool to identify the molecular signatures of serious diseases — without any previous knowledge of what these microscopic signatures or “biomarkers” should look like.
Chemists are, for the first time, using a new tool to identify the molecular signatures of serious diseases — without any previous knowledge of what these microscopic signatures or “biomarkers” should look like.